Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events

Amsterdam, 06 October 2020: Informa Markets announces its complete listing of  pharma event dates for 2021 at the opening of the first CPhI Festival of Pharma (05 - 16 October 2020) – the largest ever virtual pharma event.

The pharma schedule includes one further event in 2020: CPhI China, 16-18 December (hybrid event, combining “live” in-person with “virtual”). In 2021, all eight international CPhI editions [Worldwide, India, China, North America, Middle East & Africa, South East Asia, Korea and Japan] will return in full along with Pharmapack Europe.

The 2021 events will be enhanced by digital elements, providing greater networking and learning opportunities to the global pharma industry, with the complete pharma portfolio resuming late spring onwards. 

“We are thrilled about coming together with the pharma community again at CPhI Festival of Pharma, and we wanted to give details of all our pharma events for the year ahead. In 2021 we are implementing a hybrid model of events delivery, with virtual and online offerings, as well as live editions to provide greater flexibility to pharma companies and executives” commented Adam Andersen, Group Director of the Pharma Portfolio at Informa Markets.

Confirmed pharma event dates

16-18 December 2020:                       CPhI China (hybrid, live + virtual)

27-29 January:                                    CPhI India

14-16 April:                                        CPhI Japan

19-20 May:                                          Pharmapack Europe

22-24 June:                                        CPhI China

4-6 August:                                         CPhI SEA

10-12  August:                                    CPhI North America

31 Aug-2 Sept:                                   CPhI Worldwide

26-28 September:                               CPhI MEA

11-13 October:                                   CPhI Korea

24-26 November:                                CPhI India

To ensure the highest possible attendee safety, the organisers are working closely with local governments and authorities, and all future pharma events will feature the Informa AllSecure enhanced health and safety standards – providing the most robust at-event biosafety measures, spanning dozens of special safety protocols.

Andersen added,Over the last 31 years, CPhI has created a unique platform to unite specialist communities dedicated to improving healthcare. We provide a place where professionals can meet, exchange knowledge and do business. But it’s the real-world impact of their work that inspires us to continually adapt our offering to meet their needs. So while our events are tailored to regional requirements, their reach and significance to patients is truly global.”

Additionally, the CPhI team will continue to empower the industry with the highest quality digital content, created in collaboration with some of the industry’s leading experts. The CPhI online platforms, CPhI-Online.com and the new Globalpharmainsights.com provide the pharma community with webinars, virtual events, analysis reports, articles and more to network and stay and informed 365 days per year.

-ENDS-

Notes to editors

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; Finished Dosage Formulation for every aspect of the finished dosage supply chain; and NEX for natural extract products, applications and solutions.  CPhI provides an online buyer and supplier directory at CPhI-Online.com.

For more information visit https://www.cphi.com

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

For more information, please visit www.informamarkets.com.

The Informa Markets annual schedule of Pharmaceutical events include: CPhI & P-MEC China 2020 (16–18 December 2020 (Virtual)); CPhI & P-MEC India 2020 (28–29 January 2021 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India); CPhI Japan (14-16 April, 2021 at the Big Sight Exhibition Centre – Tokyo, Japan); Pharmapack Europe 2021 (19-20 May, 2021 at the Paris Expo, Porte de Versailles – Paris, France); CPhI and P-MEC China 2021 (22-24 June, 2021 at SNIEC – Shanghai, China); CPhI South East Asia (4-6 August, 2021 at Challenger 2, IMPACT, Muang Thong Thani, Thailand); CPhI North America (10 August - 12 August, 2021 at Pennsylvania Convention Centre – Philadelphia, USA); CPhI, ICSE, P-MEC, FDF, InnoPack Worldwide, BioProduction (31 August – 2 September 2021 at Fiera Milano, Milan); CPhI Middle East & Africa (26-28 September, 2021 at the Riyadh International Convention & Exhibition Center, Riyadh, Saudi Arabia); CPhI Korea (11-13 August 2021), COEX – Seoul, Korea); CPhI & P-MEC India 2021 (23–25 January 2021 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India);

For media enquiries, please contact:

Alex Heeley or Abdul Khalifeh

De Facto Communications

T: +44 (0) 203 735 8168

E: a.heeley@defacto.co.uk / a.khalifeh@defacto.co.uk

Back to news